Ellansé

Expert's Guide

A novel approach to the art of injecting: All you need to know to master Ellansé

In the past 20 years, our understanding of one of the most complex areas of the human body – the face – has improved dramatically, with several new anatomical structures having been identified.

At the same time, a plethora of non-surgical procedures have become available for treating the signs of ageing and restoring the youthful appearance of the face.

Ellansé® is the first, and currently the only, collagen stimulator that is made of polycaprolactone microspheres, which contribute to its durable aesthetic enhancements. Ellansé’s unique properties mean it is a desirable option for a range of soft-tissue procedures.

In addition to independent and authoritative contributions from leading physicians in the field of aesthetics, this book incorporates the latest technology to deliver augmented reality assets that bring the Ellansé injection techniques to life.

Ellanse Doctors Book

Facial anatomy and the consequences of ageing are covered, before recognised experts share best practice on patient preparation, injection technique and avoidance and management of complications and adverse events.

This book aims to support clinicians who have completed Ellansé injection training in their ongoing efforts to provide an optimal patient experience to those seeking to preserve their youthful appearance, balance or enhance facial features, or offset the effects of ageing.

Having read the book, you will be confident in the optimal use and benefits of Ellansé, becoming increasingly motivated to employ more advanced techniques and offer safer treatment to patients.

We at Sinclair hope you find this book rewarding and informative as it accompanies you on your Ellansé journey.

Contact us
Ellanse Collagen Stimulator

Contents

01 – Introducing Ellansé®

02 – Anatomy of the Face

03 – The Ageing Process

04 – Patient Selection and Preparation

05 – Injection Techniques

06 – Case Studies

07 – Combined Treatments

08 – Adverse Event Management

Ellanse Physicians Book

Our Expert’s testimonials

Click the link below to download « Chapter 1: Introducing Ellansé » in preview

Fill the form below to request your Ellansé Expert’s guide:

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

INDICATION:

The EU approved intended use is: Ellansé (a Poly-ɛ-caprolactone-based dermal filler) is an injectable implant, indicated for subdermal implantation in the face for the lasting correction of wrinkles and facial aging signs or conditions.

Important Safety Considerations:

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising.

Other potential adverse events include

- Injection related reactions, include itching, discoloration or tenderness may occur at the site of the injection. These usually resolve spontaneously within several days after the injection.

- As with any implant material possible adverse reactions that may occur include, but are not limited to the following: hypersensitivity, allergic reactions, inflammation, infection, fistula formation, haematoma, seroma, extrusion, induration formation, inadequate healing, skin discoloration, oedema, contusions/bruises, ecchymosis, inadequate or excessive augmentation, loss of correction, interference with local circulation if injected into a blood vessel resulting in vessel laceration, occlusion, embolism, infarction, and abscess at implant site which may result in induration and/or scar formation.

- Rare but serious adverse events associated with the intravascular injection of soft tissue fillers in the face have been reported and include temporary or permanent vision impairment, blindness, cerebral ischemia or cerebral hemorrhage, leading to stroke, skin necrosis, damage to underlying facial structures, nausea and vomiting, lack of ocular movement, significant skin changes, ptosis, exotropia and neurological complications.

- Adverse events, other than mentioned above, could occur as can be with any medical intervention.

All (potential) adverse side effects and incidents should be reported immediately to the Sinclair Pharma Corporate Safety Group: quality@sinclairpharma.com